JOHN LASZLO, M.D.
"Let the jury consider the verdict," the King said, for about the twentieth time that day. "No, no!" said the Queen. "Sentence first—verdict afterwards." (1)
It would be a challenge even to Alice to find a way through the issues of science, regulation, and public welfare in the topsy-turvy world of medicinal uses of marijuana and its derivatives.
An elegant study reported in this issue by Chang and associates (2) tested the efficacy of a purified synthetic derivative of marijuana, delta-9-tetrahydrocannabinol (THC), as an antiemetic for a group of young patients receiving methotrexate treatment for osteogenic sarcoma. During repeated courses
Learn more about subscription options.
Register Now for a free account.
LASZLO J. Tetrahydrocannabinol: From Pot to Prescription?. Ann Intern Med. 1979;91:916–918. doi: 10.7326/0003-4819-91-6-916
Download citation file:
Published: Ann Intern Med. 1979;91(6):916-918.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only